Page last updated: 2024-10-24

verapamil and Uremia

verapamil has been researched along with Uremia in 23 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research Excerpts

ExcerptRelevanceReference
"The aim of the present study was to examine calcium metabolism of the renal cortex in experimental chronic renal failure, together with morphologic criteria of nephrocalcinosis and to determine the effect of chronic verapamil administration on these parameters."7.67Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. ( Chaimovitz, C; Goldstein, J; Goligorsky, MS; Kol, R; Rapoport, J, 1985)
"The aim of the present study was to examine calcium metabolism of the renal cortex in experimental chronic renal failure, together with morphologic criteria of nephrocalcinosis and to determine the effect of chronic verapamil administration on these parameters."3.67Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. ( Chaimovitz, C; Goldstein, J; Goligorsky, MS; Kol, R; Rapoport, J, 1985)
" Pharmacokinetic parameters obtained after oral administration were not significantly different from those after intravenous dosing."2.65Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients. ( Larsen, A; Midtbø, K; Saevareid, L; Storstein, L, 1984)
"Mycophenolic acid was detected in all cats."2.61 ( Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019)
"Verapamil blunted the increase in plasma potassium in diabetic and nondiabetic rats compared with the respective controls."1.29Effect of verapamil on disposition of intravenous potassium in diabetic anephric uremic rats. ( Blum, M; Cabili, S; Davidovics, Y; Iaina, A; Peer, G; Serban, I; Wollman, Y, 1993)
" An increased pressor responsiveness to noradrenaline was indicated by a shift of the noradrenaline dose-response curve to the left in group A rats as compared with group C rats."1.27Vascular hypersensitivity to noradrenaline: a possible mechanism of hypertension in rats with chronic uraemia. ( Chaichenco, Y; Chaimovitz, C; Goligorsky, M; Kaplanski, J; Rapoport, J; Zimlichman, RR, 1984)
" There was a dose-response relationship between both moieties of PTH and the rise in heart beats, but the effect of 1-84 PTH was significantly greater than that of 1-34 moiety."1.26Effect of parathyroid hormone on rat heart cells. ( Bogin, E; Harary, I; Massry, SG, 1981)

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-199015 (65.22)18.7374
1990's6 (26.09)18.2507
2000's1 (4.35)29.6817
2010's1 (4.35)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bobenko, AI1
Heller, S1
Schmitt, N1
Cherdtrakulkiat, R1
Lawung, R1
Nabu, S1
Tantimavanich, S1
Sinthupoom, N1
Prachayasittikul, S1
Prachayasittikul, V1
Zhang, B1
Wu, C1
Zhang, Z2
Yan, K1
Li, C2
Li, Y4
Li, L3
Zheng, C1
Xiao, Y1
He, D1
Zhao, F1
Su, JF1
Lun, SM1
Hou, YJ1
Duan, LJ1
Wang, NC1
Shen, FF1
Zhang, YW1
Gao, ZW1
Li, J5
Du, XJ1
Zhou, FY1
Yin, Z1
Zhu, J2
Yan, D1
Lou, H1
Yu, H1
Feng, C1
Wang, Z1
Wang, Y4
Hu, X1
Li, Z2
Shen, Y1
Hu, D1
Chen, H1
Wu, X1
Duan, Y1
Zhi, D1
Zou, M2
Zhao, Z1
Zhang, X2
Yang, X2
Zhang, J2
Wang, H1
Popović, KJ1
Popović, DJ1
Miljković, D1
Lalošević, D1
Čapo, I1
Popović, JK1
Liu, M1
Song, H2
Xing, Z1
Lu, G1
Chen, D1
Valentini, AM1
Di Pinto, F1
Coletta, S1
Guerra, V1
Armentano, R1
Caruso, ML1
Gong, J1
Wang, N1
Bian, L1
Wang, M1
Ye, M1
Wen, N1
Fu, M1
Fan, W1
Meng, Y1
Dong, G1
Lin, XH1
Liu, HH1
Gao, DM1
Cui, JF1
Ren, ZG1
Chen, RX1
Önal, B1
Özen, D1
Demir, B1
Akkan, AG1
Özyazgan, S1
Payette, G1
Geoffroy, V1
Martineau, C1
Villemur, R1
Jameel, T1
Baig, M1
Gazzaz, ZJ1
Tashkandi, JM1
Al Alhareth, NS1
Khan, SA1
Butt, NS1
Wang, J2
Geng, Y1
Zhang, Y3
Wang, X2
Liu, J2
Basit, A1
Miao, T1
Liu, W1
Jiang, W1
Yu, ZY1
Wu, L2
Qu, B1
Sun, JX1
Cai, AL1
Xie, LM1
Groeneveld, J1
Ho, SL1
Mackensen, A1
Mohtadi, M1
Laepple, T1
Genovesi, S1
Nava, E1
Bartolucci, C1
Severi, S1
Vincenti, A1
Contaldo, G1
Bigatti, G1
Ciurlino, D1
Bertoli, SV1
Slovak, JE1
Hwang, JK1
Rivera, SM1
Villarino, NF1
Li, S1
Cao, G1
Ling, M1
Ji, J1
Zhao, D1
Sha, Y1
Gao, X1
Liang, C2
Guo, Q1
Zhou, C1
Ma, Z1
Xu, J1
Wang, C1
Zhao, W1
Xia, X1
Jiang, Y1
Peng, J1
Jia, Z1
Li, F1
Chen, X2
Mo, J1
Zhang, S2
Li, X1
Huang, T1
Zhu, Q1
Wang, S1
Ge, RS1
Fortunato, G1
Lin, J2
Agarwal, PK1
Kohen, A1
Singh, P1
Cheatum, CM1
Zhu, D1
Hayman, A1
Kebede, B1
Stewart, I1
Chen, G1
Frew, R1
Guo, X1
Gong, Q1
Borowiec, J1
Han, S1
Zhang, M1
Willis, M1
Kreouzis, T1
Yu, K1
Chirvony, VS1
Sekerbayev, KS1
Pérez-Del-Rey, D1
Martínez-Pastor, JP1
Palazon, F1
Boix, PP1
Taurbayev, TI1
Sessolo, M1
Bolink, HJ1
Lu, M1
Lan, Y1
Xiao, J1
Song, M1
Chen, C1
Huang, Q1
Cao, Y1
Ho, CT1
Qi, B1
Wang, Q1
Zhang, W1
Fang, L1
Xie, CL1
Chen, R1
Yang, S1
Xia, JM1
Zhang, GY1
Chen, CH1
Yang, XW1
Domenech-Ximenos, B1
Garza, MS1
Prat-González, S1
Sepúlveda-Martínez, Á1
Crispi, F1
Perea, RJ1
Garcia-Alvarez, A1
Sitges, M1
Kalumpha, M1
Guyo, U1
Zinyama, NP1
Vakira, FM1
Nyamunda, BC1
Varga, M1
Drácz, L1
Kolbenheyer, E1
Varga, F1
Patai, ÁV1
Solymosi, N1
Patai, Á1
Kiss, J1
Gaál, V1
Nyul, Z1
Mosdósi, B1
Valdez, M1
Moosavi, L1
Heidari, A1
Novakovic-Agopian, T1
Kornblith, E1
Abrams, G1
McQuaid, JR1
Posecion, L1
Burciaga, J1
D'Esposito, M1
Chen, AJW1
Samy El Gendy, NM1
Wesolowska, P1
Georg, D1
Lechner, W1
Kazantsev, P1
Bokulic, T1
Tedgren, AC1
Adolfsson, E1
Campos, AM1
Alves, VGL1
Suming, L1
Hao, W1
Ekendahl, D1
Koniarova, I1
Bulski, W1
Chelminski, K1
Samper, JLA1
Vinatha, SP1
Rakshit, S1
Siri, S1
Tomsejm, M1
Tenhunen, M1
Povall, J1
Kry, SF1
Followill, DS1
Thwaites, DI1
Izewska, J1
Kang, JH1
Yoon, Y1
Song, J1
Van de Winckel, A1
Gauthier, L1
Chao, CT1
Lee, YH1
Li, CM1
Han, DS1
Huang, JW1
Huang, KC1
Ni, L1
Güttinger, R1
Triana, CA1
Spingler, B1
Baldridge, KK1
Patzke, GR1
Shen, X1
Wang, B1
Xie, S1
Deng, W1
Wu, D1
Zhang, Q1
Voskamp, BJ1
Peelen, MJCS1
Ravelli, ACJ1
van der Lee, R1
Mol, BWJ1
Pajkrt, E1
Ganzevoort, W1
Kazemier, BM1
Tibrewala, R1
Bahroos, E1
Mehrabian, H1
Foreman, SC1
Link, TM1
Pedoia, V1
Majumdar, S1
Jablonski, CL1
Leonard, C1
Salo, P1
Krawetz, RJ1
Yoon, N1
Hong, SN1
Cho, JG1
Jeong, HK1
Lee, KH1
Park, HW1
Barman, S1
Konai, MM1
Samaddar, S1
Haldar, J1
Mohamed, HSH1
Li, CF1
Hu, ZY1
Deng, Z1
Chen, LH1
Su, BL1
Chu, K1
Liu, YP1
Li, YB1
Zhang, H1
Xu, C1
Zou, Z1
Wu, Z1
Xia, Y1
Zhao, P1
Wang, HT1
de Biase, S1
Pellitteri, G1
Gigli, GL1
Valente, M1
Bogin, E4
Massry, SG2
Harary, I1
Goligorsky, MS2
Chaimovitz, C3
Shany, S1
Rapoport, J3
Sharony, Y1
Storstein, L1
Larsen, A1
Midtbø, K1
Saevareid, L1
Earon, Y2
Blum, M3
Zimlichman, RR1
Chaichenco, Y1
Goligorsky, M1
Kaplanski, J1
Cohen, EP1
Moulder, JE1
Fish, BL1
Hill, P1
Davidovics, Y1
Peer, G1
Cabili, S1
Serban, I1
Wollman, Y1
Iaina, A1
Stojceva-Taneva, O1
Fadda, GZ1
Smogorzewski, M1
Smogorzewski, MJ1
Robles, NR1
García Díaz, MC1
Fernández Mora, G1
Sánchez Casado, E1
Smeda, JS1
Azzadin, A1
Pietraszek, MH1
Buczko, W1
Carozzi, S1
Nasini, MG1
Schelotto, C1
Caviglia, PM1
Santoni, O1
Barocci, S1
Versace, F1
Cantaluppi, A1
Salit, M1
Lamperi, S1
Krog, M1
Ejerblad, S1
Johansson, H1
Pettersson, L1
Chagnac, A3
Gazit, D1
Zahavi, I2
Sela, J1
Levi, J3
Benigni, A1
Livio, M1
Dodesini, P1
Schieppati, A1
Panigada, M1
Mecca, G1
de Gaetano, G1
Remuzzi, G1
Jüppner, H1
Johannessen, AC1
Poulsen, S2
Goldstein, J1
Kol, R1
Johannessen, A1
Rendtorff, C1
Djaldetti, M1
Katz, M1

Reviews

2 reviews available for verapamil and Uremia

ArticleYear
    Proceedings. Mathematical, physical, and engineering sciences, 2019, Volume: 475, Issue:2227

    Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, P

2019
Central nervous dysfunction in uremia.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:4 Suppl 1

    Topics: Adenosine Triphosphate; Animals; Atrophy; Brain; Brain Diseases; Calcium; Cytosol; Humans; Kidney Fa

2001

Trials

1 trial available for verapamil and Uremia

ArticleYear
Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients.
    Acta medica Scandinavica. Supplementum, 1984, Volume: 681

    Topics: Administration, Oral; Adult; Aged; Aging; Diltiazem; Humans; Injections, Intravenous; Kinetics; Male

1984

Other Studies

20 other studies available for verapamil and Uremia

ArticleYear
Effect of parathyroid hormone on rat heart cells.
    The Journal of clinical investigation, 1981, Volume: 67, Issue:4

    Topics: Animals; Calcimycin; Calcium; Catecholamines; Cyclic AMP; Heart; In Vitro Techniques; Myocardium; Pa

1981
Verapamil improves defective intestinal calcium absorption in uremia.
    Advances in experimental medicine and biology, 1984, Volume: 178

    Topics: Animals; Calcium; Duodenum; Intestinal Absorption; Kidney Cortex; Male; Nephrectomy; Radioimmunoassa

1984
Effect of parathyroid hormone and uremic sera on the autoagglutination and sedimentation of human red blood cells.
    Clinica chimica acta; international journal of clinical chemistry, 1983, Dec-30, Volume: 135, Issue:3

    Topics: Blood Sedimentation; Calcium; Dose-Response Relationship, Drug; Hemagglutination; Humans; Hydrogen-I

1983
Vascular hypersensitivity to noradrenaline: a possible mechanism of hypertension in rats with chronic uraemia.
    Clinical science (London, England : 1979), 1984, Volume: 67, Issue:2

    Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Renal; Male;

1984
Prophylaxis of experimental bone marrow transplant nephropathy.
    The Journal of laboratory and clinical medicine, 1994, Volume: 124, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bone Mar

1994
Effect of verapamil on disposition of intravenous potassium in diabetic anephric uremic rats.
    Mineral and electrolyte metabolism, 1993, Volume: 19, Issue:2

    Topics: Animals; Diabetes Mellitus, Experimental; Nephrectomy; Potassium; Potassium Chloride; Rats; Rats, Sp

1993
Parathyroid hormone increases cytosolic calcium of thymocytes.
    Nephron, 1993, Volume: 64, Issue:4

    Topics: Animals; Bucladesine; Calcium; Colforsin; Cytosol; In Vitro Techniques; Male; Parathyroid Hormone; P

1993
[Poisoning by delayed-release verapamil in an uremic patient].
    Medicina clinica, 1992, Dec-05, Volume: 99, Issue:19

    Topics: Chemical and Drug Induced Liver Injury; Delayed-Action Preparations; Dose-Response Relationship, Dru

1992
Cerebral vascular changes associated with hemorrhagic stroke in hypertension.
    Canadian journal of physiology and pharmacology, 1992, Volume: 70, Issue:4

    Topics: Aging; Animals; Cerebral Arteries; Cerebral Hemorrhage; Cerebrovascular Circulation; Cerebrovascular

1992
Effects of verapamil on some parameters of haemostasis in rats with experimental chronic renal failure.
    Thrombosis research, 1990, Oct-01, Volume: 60, Issue:1

    Topics: Animals; Blood Coagulation; Blood Platelets; Cyclic AMP; Hemostasis; Male; Platelet Aggregation; Rat

1990
Effects of Ca++ and 1,25(OH)2D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1989, Volume: 5

    Topics: Adult; Calcitriol; Calcium; Cell Division; Cytokines; Dose-Response Relationship, Drug; Female; Fibr

1989
Tissue calcium in uraemia.
    Scandinavian journal of urology and nephrology, 1989, Volume: 23, Issue:2

    Topics: Animals; Aorta, Thoracic; Calcitriol; Calcium; Kidney; Male; Myocardium; Rats; Rats, Inbred Strains;

1989
Effect of verapamil on bone resorption and formation in uremic rats.
    Mineral and electrolyte metabolism, 1989, Volume: 15, Issue:5

    Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Creatinine; Hyperparathyroidism; Kidney Failure,

1989
Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated?
    American journal of nephrology, 1985, Volume: 5, Issue:4

    Topics: Adenylyl Cyclases; Blood Platelets; Calcimycin; Calcium; Cyclic AMP; Humans; In Vitro Techniques; Pa

1985
Effect of verapamil on plasma parathyroid hormone.
    Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie, 1987, Volume: 25, Issue:2

    Topics: Acute Kidney Injury; Animals; Calcium; Male; Parathyroid Hormone; Rats; Rats, Inbred Strains; Urea;

1987
Effect of parathyroid hormone and uremia on erythrocyte deformability.
    Clinica chimica acta; international journal of clinical chemistry, 1986, Dec-30, Volume: 161, Issue:3

    Topics: Calcium; Dose-Response Relationship, Drug; Erythrocyte Deformability; Humans; Hydrogen-Ion Concentra

1986
[Verapamil-induced digoxin poisoning in uremia].
    Ugeskrift for laeger, 1985, May-06, Volume: 147, Issue:19

    Topics: Digoxin; Drug Interactions; Female; Humans; Middle Aged; Renal Dialysis; Uremia; Verapamil

1985
Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil.
    Kidney international, 1985, Volume: 27, Issue:5

    Topics: Animals; Calcium; Kidney Cortex; Male; Nephrectomy; Nephrocalcinosis; Rats; Uremia; Verapamil

1985
Digoxin intoxication induced by verapamil in an uremic patient.
    Clinical nephrology, 1985, Volume: 24, Issue:3

    Topics: Digoxin; Drug Interactions; Female; Humans; Kinetics; Middle Aged; Renal Dialysis; Uremia; Verapamil

1985
Effect of verapamil on uremic myocardial disease in the rat.
    Journal of submicroscopic cytology, 1985, Volume: 17, Issue:4

    Topics: Animals; Blood Urea Nitrogen; Cardiomyopathies; Creatinine; Male; Microscopy, Electron; Myocardium;

1985